Stock Market & Financial Investment News

News Breaks December 10, 2012 06:44 EDT PBYI Puma Biotechnology price target raised to $27 from $20 at Leerink Leerink raised its price target for Puma Biotechnology citing the company's progress in advancing neratinib. The firm keeps an Outperform rating on the stock. News For PBYI From The Last 14 Days Check below for free stories on PBYI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 14:35 EDT PBYI Puma Biotechnology declines to comment on stock move Subscribe for More Information May 9, 2013 16:38 EDT PBYI Puma Biotechnology reports Q1 adjusted EPS (36c), consensus (59c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.